UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct‐acting antivirals

Journal of viral hepatitis, 2018-07, Vol.25 (7), p.870-873

2018

Volltextzugriff (PDF)

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

Journal of Virus Eradication, 2023-03, Vol.9 (1), p.100319-100319, Article 100319

2023

Volltextzugriff (PDF)

Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Journal of hepatology, 2017, Vol.66 (1), p.S740-S740

2017

Volltextzugriff (PDF)

Direct Observed Therapy of Chronic Hepatitis C with Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility – a New Concept for Treatment of Patients with Borderline Compliance Receiving Opioid Substitution Therapy

Journal of hepatology, 2016, Vol.64 (2), p.S822-S822

2016

Volltextzugriff (PDF)

Alkohol 2020“: Ein integriertes Versorgungssystem für Menschen mit einer Alkoholerkrankung in Wien

Suchttherapie, 2015-08, Vol.16 (S 01)

2015

Volltextzugriff (PDF)

FRI-391 - High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

Journal of hepatology, 2018-04, Vol.68, p.S538-S538

2018

Volltextzugriff (PDF)

High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

Journal of hepatology, 2018-04, Vol.68, p.S538

2018

Volltextzugriff (PDF)

SAT-268 - Direct Observed Therapy of Chronic Hepatitis C with Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility – a New Concept for Treatment of Patients with Borderline Compliance Receiving Opioid Substitution Therapy

Journal of hepatology, 2016, Vol.64 (2), p.S822-S822

2016

Volltextzugriff (PDF)

SAT-278 - Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Journal of hepatology, 2017, Vol.66 (1), p.S740-S740

2017

Volltextzugriff (PDF)

Individualized treatment of chronic hepatitis C in patients receiving opioid substitution therapy

Zeitschrift für Gastroenterologie, 2016, Vol.54 (5)

2016

Volltextzugriff (PDF)

Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Zeitschrift für Gastroenterologie, 2017, Vol.55 (5), p.e28-e56

2017

Volltextzugriff (PDF)

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Zeitschrift für Gastroenterologie, 2015, Vol.53 (5)

2015

Volltextzugriff (PDF)

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm

Nature genetics, 2010-08, Vol.42 (8), p.692-697

2010

Volltextzugriff (PDF)

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies

Circulation. Cardiovascular genetics, 2012-02, Vol.5 (1), p.100-112

2012

Volltextzugriff (PDF)

Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women

Arteriosclerosis, thrombosis, and vascular biology, 2005-03, Vol.25 (3), p.604-610

2005

Volltextzugriff (PDF)

Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease

European heart journal, 2013-08, Vol.34 (suppl 1), p.2778-2778

2013

Volltextzugriff (PDF)

Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium

Atherosclerosis, 2012-05, Vol.222 (1), p.138-147

2012

Volltextzugriff (PDF)

Hepatic lipase polymorphism and increased risk of peripheral arterial disease

Journal of internal medicine, 2005-10, Vol.258 (4), p.344-348

2005

Volltextzugriff (PDF)

The MTP −493TT genotype is associated with peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) Study

Clinical biochemistry, 2008-06, Vol.41 (9), p.712-716

2008

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(16)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Directly observed therapy of chronic hepatitis C with ledipasvir/sofosbuvir in people who inject drugs at risk of nonadherence to direct‐acting antivirals

Combining treatment for chronic hepatitis C with opioid agonist therapy is an effective microelimination strategy for people who inject drugs with high risk of non-adherence to direct-acting antiviral therapy

Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Direct Observed Therapy of Chronic Hepatitis C with Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility – a New Concept for Treatment of Patients with Borderline Compliance Receiving Opioid Substitution Therapy

Alkohol 2020“: Ein integriertes Versorgungssystem für Menschen mit einer Alkoholerkrankung in Wien

FRI-391 - High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

High virological cure rate and low rate of reinfection in a project to eradicate HCV in people who inject drugs at risk for non-adherence to direct-acting antivirals in Vienna

SAT-268 - Direct Observed Therapy of Chronic Hepatitis C with Interferon-Free All-Oral Regimens at a Low-Threshold Drug Treatment Facility – a New Concept for Treatment of Patients with Borderline Compliance Receiving Opioid Substitution Therapy

SAT-278 - Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Individualized treatment of chronic hepatitis C in patients receiving opioid substitution therapy

Directly observed therapy with sofosbuvir/ledipasvir for 8 weeks is highly effective in treatment-naïve, precirrhotic genotype 1 patients with borderline compliance receiving opioid agonist therapy

Direct observed therapy of chronic Hepatitis C with an interferon-free all-oral regimen at a low-threshold drug treatment facility – a new concept for treatment of patients with borderline compliance receiving Opioid substitution therapy

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm

Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies

Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women

Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease

Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium

Hepatic lipase polymorphism and increased risk of peripheral arterial disease

The MTP −493TT genotype is associated with peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) Study

Suchergebnisse filtern